title: Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept.
authors.affiliation: Rheumatology Research Unit, Department of Clinical and Experimental Medicine, University Federico II, Naples, Italy.
authors.forename: Luisa
authors.initials: L
authors.lastname: Costa
authors.forename: Mariangela
authors.initials: M
authors.lastname: Atteno
authors.forename: Francesco
authors.initials: F
authors.lastname: Caso
authors.forename: Luigi
authors.initials: L
authors.lastname: Scarpato
authors.forename: Antonio
authors.initials: A
authors.lastname: Del Puente
authors.forename: Raffaele
authors.initials: R
authors.lastname: Scarpa
mesh_terms: D000328:Adult; D000506:Alopecia Areata / Q000139:chemically induced* / Q000175:diagnosis; D015535:Arthritis, Psoriatic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D003424:Crohn Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D018124:Receptors, Tumor Necrosis Factor; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept